United States Biotechnology & Medical Research

Nurix Therapeutics Inc (NRIX)

Track

Over the past 90 days, Nurix Therapeutics Inc. insiders have executed 21 transactions, all of which were sales totaling approximately $3.91 million. Key executives, including the Chief Scientific Officer, Chief Financial Officer, and Chief Legal Officer, have consistently sold shares. These transactions follow the company's July 2026 earnings report and a 52.1% stock price increase.
Ticker: NRIX Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Nurix Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
295.05
Quantity 71,604 +21.2%
Value US$854,541
3.1
GWENN HANSEN Officer Officer
Transaction date
Proposed sale
Price
478.67
Quantity 59,820
Value US$4,518,501
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
68.69
Quantity 32,904 -1.3%
Value US$3,764,366
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
23.87
Quantity 1,000 -1.2%
Value US$100,000
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
24.65
Quantity 1,000 -6.9%
Value US$100,000
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
23.89
Quantity 1,000 -4.0%
Value US$100,000
3.1
GWENN M HANSEN Officer Officer
Transaction date
Proposed sale
Price
23.22
Quantity 1,000
Value US$100,000
3.1
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
23.22
Quantity 1,000
Value US$100,000
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
23.05
Quantity 1,000 -64.6%
Value US$100,000
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
23.21
Quantity 1,000
Value US$100,000
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
23.38
Quantity 1,000 -6.0%
Value US$100,000
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
23.38
Quantity 1,000 -16.2%
Value US$100,000
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
23.38
Quantity 1,000 -3.1%
Value US$100,000
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
23.56
Quantity 11,008 -44.8%
Value US$259,366
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
23.91
Quantity 11,008
Value US$263,201
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Planned sale
Price
20.00
Quantity 5,394 -4.5%
Value US$107,880
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
20.06
Quantity 28,935 -68.1%
Value US$580,506
3.1
GWENN M HANSEN Officer Officer
Transaction date
Proposed sale
Price
19.30
Quantity 5,394
Value US$104,104
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
19.30
Quantity 28,935
Value US$558,446
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.60
Quantity 8,148 -37.5%
Value US$135,253
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
17.39
Quantity 8,148
Value US$141,694
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
17.18
Quantity 582 -1.5%
Value US$9,996
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
16.58
Quantity 13,473 -26.1%
Value US$223,323
3.1
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
16.93
Quantity 14,055
Value US$237,951
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.96
Quantity 8,148 -30.8%
Value US$138,210
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.81
Quantity 8,148
Value US$136,968
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.76
Quantity 5,394 -16.9%
Value US$90,407
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.70
Quantity 5,394
Value US$90,080
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
16.65
Quantity 2,388 -4.4%
Value US$39,749
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
16.65
Quantity 3,214 -2.6%
Value US$53,498
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
16.65
Quantity 3,214 -9.2%
Value US$53,498
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
15.24
Quantity 8,148 -23.5%
Value US$124,149
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
15.48
Quantity 8,148
Value US$126,131
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
15.44
Quantity 8,148 -19.1%
Value US$125,793
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
15.97
Quantity 8,148
Value US$130,124
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
16.66
Quantity 14,261 -25.0%
Value US$237,618
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.85
Quantity 14,261
Value US$240,298
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
17.37
Quantity 73 -0.2%
Value US$1,268
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
16.58
Quantity 3,588 -7.3%
Value US$59,498
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
17.37
Quantity 98 -0.1%
Value US$1,702
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
16.58
Quantity 4,797 -5.4%
Value US$79,547
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
17.37
Quantity 88 -0.2%
Value US$1,529
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
16.58
Quantity 4,333 -7.1%
Value US$71,852
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.42
Quantity 3,760 -6.9%
Value US$69,273
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
18.21
Quantity 7,520
Value US$136,939
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
18.56
Quantity 200 -0.4%
Value US$3,711
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
17.87
Quantity 3,560 -6.5%
Value US$63,603
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
16.76
Quantity 37,600
Value US$630,176
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
17.07
Quantity 37,600 -42.5%
Value US$641,697
3.1
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
12.94
Quantity 6,284
Value US$81,315
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
12.56
Quantity 6,284 -14.3%
Value US$78,931
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
12.80
Quantity 3,130 -6.7%
Value US$40,054
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
12.80
Quantity 4,087 -5.1%
Value US$52,300
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
12.80
Quantity 3,644 -6.7%
Value US$46,631
3.1
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
11.26
Quantity 5,402
Value US$60,827
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.03
Quantity 5,402 -13.2%
Value US$59,598
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
12.01
Quantity 4,304 -9.5%
Value US$51,695
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
12.01
Quantity 3,841 -8.0%
Value US$46,134
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
12.01
Quantity 4,308 -5.9%
Value US$51,743
3.1
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
11.16
Quantity 6,198
Value US$69,170
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
11.33
Quantity 6,198 -15.5%
Value US$70,243
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
11.50
Quantity 3,377 -5.2%
Value US$38,841
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
11.50
Quantity 2,438 -5.8%
Value US$28,041
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
11.50
Quantity 2,894 -7.2%
Value US$33,286
3.1
JOHANNES VAN HOUTE Officer Officer
Transaction date
Proposed sale
Price
15.45
Quantity 5,825
Value US$89,996
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
15.13
Quantity 700 -2.0%
Value US$10,591
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Planned sale
Price
14.40
Quantity 5,125 -13.0%
Value US$73,797
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
20.48
Quantity 100 -0.3%
Value US$2,048
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Planned sale
Price
19.94
Quantity 5,660 -14.8%
Value US$112,886
3.2
CHRISTINE RING Officer Officer
Transaction date
Proposed sale
Price
20.02
Quantity 5,760
Value US$115,286
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
20.33
Quantity 291 -0.9%
Value US$5,915
3.2
Ring Christine Chief Legal Officer Officer
Transaction date
Sale
Price
19.81
Quantity 2,929 -8.2%
Value US$58,014
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
20.33
Quantity 254 -0.6%
Value US$5,163
3.1
van Houte Hans Chief Financial Officer Officer
Transaction date
Sale
Price
19.81
Quantity 2,557 -6.0%
Value US$50,646
3.1
Hansen Gwenn Chief Scientific Officer Officer
Transaction date
Sale
Price
20.33
Quantity 333 -0.6%
Value US$6,768
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-08-05 PlS Planned sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
71,604 +21.2%
295.05
US$854,541 		71,604 +21.2% 295.05 US$854,541
2026-08-05 2026-08-05 PrS Proposed sale
3.1
GWENN HANSEN

Officer

Officer
59,820
478.67
US$4,518,501 		59,820 478.67 US$4,518,501
2026-08-05 2026-08-04 PlS Planned sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
32,904 -1.3%
68.69
US$3,764,366 		32,904 -1.3% 68.69 US$3,764,366
2026-08-05 2026-08-04 PlS Planned sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
1,000 -1.2%
23.87
US$100,000 		1,000 -1.2% 23.87 US$100,000
2026-08-04 2026-08-04 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
1,000 -6.9%
24.65
US$100,000 		1,000 -6.9% 24.65 US$100,000
2026-08-04 2026-08-04 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
1,000 -4.0%
23.89
US$100,000 		1,000 -4.0% 23.89 US$100,000
2026-08-04 2026-08-04 PrS Proposed sale
3.1
GWENN M HANSEN

Officer

Officer
1,000
23.22
US$100,000 		1,000 23.22 US$100,000
2026-08-04 2026-08-04 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
1,000
23.22
US$100,000 		1,000 23.22 US$100,000
2026-08-03 2026-08-03 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
1,000 -64.6%
23.05
US$100,000 		1,000 -64.6% 23.05 US$100,000
2026-08-03 2026-08-03 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
1,000
23.21
US$100,000 		1,000 23.21 US$100,000
2026-07-30 2026-07-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
1,000 -6.0%
23.38
US$100,000 		1,000 -6.0% 23.38 US$100,000
2026-07-30 2026-07-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
1,000 -16.2%
23.38
US$100,000 		1,000 -16.2% 23.38 US$100,000
2026-07-30 2026-07-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
1,000 -3.1%
23.38
US$100,000 		1,000 -3.1% 23.38 US$100,000
2026-07-02 2026-07-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
11,008 -44.8%
23.56
US$259,366 		11,008 -44.8% 23.56 US$259,366
2026-07-02 2026-07-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
11,008
23.91
US$263,201 		11,008 23.91 US$263,201
2026-06-25 2026-06-25 PlS Planned sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
5,394 -4.5%
20.00
US$107,880 		5,394 -4.5% 20.00 US$107,880
2026-06-25 2026-06-25 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
28,935 -68.1%
20.06
US$580,506 		28,935 -68.1% 20.06 US$580,506
2026-06-25 2026-06-25 PrS Proposed sale
3.1
GWENN M HANSEN

Officer

Officer
5,394
19.30
US$104,104 		5,394 19.30 US$104,104
2026-06-25 2026-06-25 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
28,935
19.30
US$558,446 		28,935 19.30 US$558,446
2026-06-02 2026-06-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
8,148 -37.5%
16.60
US$135,253 		8,148 -37.5% 16.60 US$135,253
2026-06-02 2026-06-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
8,148
17.39
US$141,694 		8,148 17.39 US$141,694
2026-05-05 2026-05-05 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
582 -1.5%
17.18
US$9,996 		582 -1.5% 17.18 US$9,996
2026-05-05 2026-05-05 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
13,473 -26.1%
16.58
US$223,323 		13,473 -26.1% 16.58 US$223,323
2026-05-05 2026-05-05 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
14,055
16.93
US$237,951 		14,055 16.93 US$237,951
2026-05-04 2026-05-04 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
8,148 -30.8%
16.96
US$138,210 		8,148 -30.8% 16.96 US$138,210
2026-05-04 2026-05-04 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
8,148
16.81
US$136,968 		8,148 16.81 US$136,968
2026-05-01 2026-05-01 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
5,394 -16.9%
16.76
US$90,407 		5,394 -16.9% 16.76 US$90,407
2026-05-01 2026-05-01 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
5,394
16.70
US$90,080 		5,394 16.70 US$90,080
2026-04-30 2026-04-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
2,388 -4.4%
16.65
US$39,749 		2,388 -4.4% 16.65 US$39,749
2026-04-30 2026-04-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
3,214 -2.6%
16.65
US$53,498 		3,214 -2.6% 16.65 US$53,498
2026-04-30 2026-04-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,214 -9.2%
16.65
US$53,498 		3,214 -9.2% 16.65 US$53,498
2026-04-02 2026-04-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
8,148 -23.5%
15.24
US$124,149 		8,148 -23.5% 15.24 US$124,149
2026-04-02 2026-04-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
8,148
15.48
US$126,131 		8,148 15.48 US$126,131
2026-03-02 2026-03-02 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
8,148 -19.1%
15.44
US$125,793 		8,148 -19.1% 15.44 US$125,793
2026-03-02 2026-03-02 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
8,148
15.97
US$130,124 		8,148 15.97 US$130,124
2026-02-09 2026-02-09 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
14,261 -25.0%
16.66
US$237,618 		14,261 -25.0% 16.66 US$237,618
2026-02-09 2026-02-09 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
14,261
16.85
US$240,298 		14,261 16.85 US$240,298
2026-01-30 2026-01-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
73 -0.2%
17.37
US$1,268 		73 -0.2% 17.37 US$1,268
2026-01-30 2026-01-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
3,588 -7.3%
16.58
US$59,498 		3,588 -7.3% 16.58 US$59,498
2026-01-30 2026-01-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
98 -0.1%
17.37
US$1,702 		98 -0.1% 17.37 US$1,702
2026-01-30 2026-01-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
4,797 -5.4%
16.58
US$79,547 		4,797 -5.4% 16.58 US$79,547
2026-01-30 2026-01-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
88 -0.2%
17.37
US$1,529 		88 -0.2% 17.37 US$1,529
2026-01-30 2026-01-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
4,333 -7.1%
16.58
US$71,852 		4,333 -7.1% 16.58 US$71,852
2026-01-20 2026-01-20 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,760 -6.9%
18.42
US$69,273 		3,760 -6.9% 18.42 US$69,273
2025-12-18 2025-12-18 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
7,520
18.21
US$136,939 		7,520 18.21 US$136,939
2025-12-18 2025-12-18 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
200 -0.4%
18.56
US$3,711 		200 -0.4% 18.56 US$3,711
2025-12-18 2025-12-18 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,560 -6.5%
17.87
US$63,603 		3,560 -6.5% 17.87 US$63,603
2025-11-24 2025-11-24 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
37,600
16.76
US$630,176 		37,600 16.76 US$630,176
2025-11-24 2025-11-24 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
37,600 -42.5%
17.07
US$641,697 		37,600 -42.5% 17.07 US$641,697
2025-11-03 2025-11-03 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
6,284
12.94
US$81,315 		6,284 12.94 US$81,315
2025-11-03 2025-11-03 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
6,284 -14.3%
12.56
US$78,931 		6,284 -14.3% 12.56 US$78,931
2025-10-30 2025-10-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
3,130 -6.7%
12.80
US$40,054 		3,130 -6.7% 12.80 US$40,054
2025-10-30 2025-10-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
4,087 -5.1%
12.80
US$52,300 		4,087 -5.1% 12.80 US$52,300
2025-10-30 2025-10-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,644 -6.7%
12.80
US$46,631 		3,644 -6.7% 12.80 US$46,631
2025-08-01 2025-08-01 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
5,402
11.26
US$60,827 		5,402 11.26 US$60,827
2025-08-01 2025-08-01 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
5,402 -13.2%
11.03
US$59,598 		5,402 -13.2% 11.03 US$59,598
2025-07-30 2025-07-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
4,304 -9.5%
12.01
US$51,695 		4,304 -9.5% 12.01 US$51,695
2025-07-30 2025-07-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
3,841 -8.0%
12.01
US$46,134 		3,841 -8.0% 12.01 US$46,134
2025-07-30 2025-07-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
4,308 -5.9%
12.01
US$51,743 		4,308 -5.9% 12.01 US$51,743
2025-05-02 2025-05-02 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
6,198
11.16
US$69,170 		6,198 11.16 US$69,170
2025-05-02 2025-05-02 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
6,198 -15.5%
11.33
US$70,243 		6,198 -15.5% 11.33 US$70,243
2025-04-30 2025-04-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
3,377 -5.2%
11.50
US$38,841 		3,377 -5.2% 11.50 US$38,841
2025-04-30 2025-04-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
2,438 -5.8%
11.50
US$28,041 		2,438 -5.8% 11.50 US$28,041
2025-04-30 2025-04-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
2,894 -7.2%
11.50
US$33,286 		2,894 -7.2% 11.50 US$33,286
2025-03-03 2025-03-03 PrS Proposed sale
3.1
JOHANNES VAN HOUTE

Officer

Officer
5,825
15.45
US$89,996 		5,825 15.45 US$89,996
2025-03-03 2025-03-03 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
700 -2.0%
15.13
US$10,591 		700 -2.0% 15.13 US$10,591
2025-03-03 2025-03-03 PlS Planned sale
3.1
van Houte Hans

Chief Financial Officer

Officer
5,125 -13.0%
14.40
US$73,797 		5,125 -13.0% 14.40 US$73,797
2025-02-03 2025-01-31 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
100 -0.3%
20.48
US$2,048 		100 -0.3% 20.48 US$2,048
2025-02-03 2025-01-31 PlS Planned sale
3.2
Ring Christine

Chief Legal Officer

Officer
5,660 -14.8%
19.94
US$112,886 		5,660 -14.8% 19.94 US$112,886
2025-01-31 2025-01-31 PrS Proposed sale
3.2
CHRISTINE RING

Officer

Officer
5,760
20.02
US$115,286 		5,760 20.02 US$115,286
2025-01-30 2025-01-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
291 -0.9%
20.33
US$5,915 		291 -0.9% 20.33 US$5,915
2025-01-30 2025-01-30 S Sale
3.2
Ring Christine

Chief Legal Officer

Officer
2,929 -8.2%
19.81
US$58,014 		2,929 -8.2% 19.81 US$58,014
2025-01-30 2025-01-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
254 -0.6%
20.33
US$5,163 		254 -0.6% 20.33 US$5,163
2025-01-30 2025-01-30 S Sale
3.1
van Houte Hans

Chief Financial Officer

Officer
2,557 -6.0%
19.81
US$50,646 		2,557 -6.0% 19.81 US$50,646
2025-01-30 2025-01-30 S Sale
3.1
Hansen Gwenn

Chief Scientific Officer

Officer
333 -0.6%
20.33
US$6,768 		333 -0.6% 20.33 US$6,768
Explore more

More insider trading research around Nurix Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America